Epitalon typical research dosing
Across the available literature, Epitalon is most commonly administered at 5000–10000 mcg per dose, 1 time(s) per day, via subcutaneous injection. Most reported protocols administer 5–10 mg daily for 10–20 days, repeated 1–2 times per year.
Epitalon unit-conversion table
The number of insulin-syringe units you draw depends on how much bacteriostatic water you used to reconstitute the vial. The table below shows units to draw on a U-100 syringe for a 50 mg Epitalon vial at common reconstitution volumes.
| Diluent (mL) | Concentration | 5000 mcg | 7500 mcg | 10000 mcg |
|---|---|---|---|---|
| 1 mL | 50000 mcg/mL | 10.0 units | 15.0 units | 20.0 units |
| 2 mL | 25000 mcg/mL | 20.0 units | 30.0 units | 40.0 units |
| 3 mL | 16667 mcg/mL | 30.0 units | 45.0 units | 60.0 units |
| 5 mL | 10000 mcg/mL | 50.0 units | 75.0 units | 100.0 units |
Epitalon cycle length
Most reported Epitalon protocols run 2 weeks on, then 24 weeks off. Cycles are used in research to study washout, receptor sensitivity, and to re-baseline endogenous signaling before re-introducing the compound.
Epitalon half-life and timing
Epitalon has a half-life of approximately 3 hours. This influences dose frequency: shorter half-lives often require multiple doses per day to maintain steady-state levels, while longer half-lives can be dosed less frequently.